Skip to main content

XPONANCE LLC

Position in APLS — Apellis Pharmaceuticals, Inc.

CIK 1637541 PHILADELPHIA, PA

Position in APLS

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$0
+$0 QoQ
Shares Held
18,550
+2.1% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2021
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in APLS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

XPONANCE LLC holds $117,846,021 across 121 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in APLS

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-03-31 18,550
2025-12-31 18,164
2025-09-30 17,483
2025-06-30 18,358
2025-03-31 16,097
2024-12-31 14,072
2024-09-30 13,323
2024-06-30 13,773
2024-03-31 12,805
2023-12-31 12,927
2023-09-30 13,866
2023-06-30 14,047
2023-03-31 5,415
2022-12-31 5,369
2022-09-30 5,255
2022-06-30 4,885
2021-06-30 3,556